• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

角度比较指数与比率和幅度变化的混合用于定量评估疾病风险、生物学功能和生物标志物疗效。

An Angle Compared Index with Hybrid of Changes in the Ratio and Amplitude for Quantitative Evaluation of Disease Risk, Biological Function, and Biomarker Efficacy.

机构信息

College of Medical Laboratory, Dalian Medical University, Dalian 116044, China.

出版信息

Biomed Res Int. 2019 Aug 5;2019:8693719. doi: 10.1155/2019/8693719. eCollection 2019.

DOI:10.1155/2019/8693719
PMID:31467916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6699270/
Abstract

OBJECTIVE

The purpose of this study was to describe variations of different cardinal frequency by using angle compared index (ACI).

METHODS

The basic principle of the analysis model is to comprehensively consider changes in both the ratio and absolute value as follows: ACI = arctan {Pd⁎(1-Pc) / [Pc⁎(1-Pd)]} + arctan (Pd - Pc) - 45, where Pd represent percentage of disease occurrence in disease group and Pc represent that in control group. The range of ACI was (0~90). Thus, ACIs from different cardinal frequency are comparable.

RESULTS

When biomarkers with similar ratio value, absolute value, or ACI but different positive frequencies were combined, although three indexes (ratio value, absolute value, or ACI) increased after two single biomarkers were combined, only ACI increased with similar amplitudes after two single biomarkers with the same ACI at different positive frequencies were combined.

CONCLUSION

The ACI provides a better understanding power of biomarker and may be a relatively good index for evaluating the complex events represented by different cardinal frequency from new systems.

摘要

目的

本研究旨在使用角度比较指数(ACI)描述不同基数频率的变化。

方法

分析模型的基本原理是全面考虑比值和绝对值的变化,如下所示:ACI=arctan[Pd*(1-Pc)/[Pc*(1-Pd)]]+arctan(Pd-Pc)-45,其中 Pd 表示疾病组中疾病发生的百分比,Pc 表示对照组中的百分比。ACI 的范围是(0~90)。因此,来自不同基数频率的 ACIs 是可比较的。

结果

当具有相似比值、绝对值或 ACI 但阳性频率不同的生物标志物组合时,尽管在两种单一生物标志物组合后,三个指标(比值、绝对值或 ACI)都增加了,但只有在两种具有相同 ACI 但阳性频率不同的单一生物标志物组合后,ACI 才以相似的幅度增加。

结论

ACI 提供了对生物标志物更好的理解能力,并且可能是评估新系统中代表不同基数频率的复杂事件的相对较好的指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a04/6699270/948ee5943638/BMRI2019-8693719.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a04/6699270/71c10d590b8d/BMRI2019-8693719.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a04/6699270/948ee5943638/BMRI2019-8693719.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a04/6699270/71c10d590b8d/BMRI2019-8693719.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a04/6699270/948ee5943638/BMRI2019-8693719.002.jpg

相似文献

1
An Angle Compared Index with Hybrid of Changes in the Ratio and Amplitude for Quantitative Evaluation of Disease Risk, Biological Function, and Biomarker Efficacy.角度比较指数与比率和幅度变化的混合用于定量评估疾病风险、生物学功能和生物标志物疗效。
Biomed Res Int. 2019 Aug 5;2019:8693719. doi: 10.1155/2019/8693719. eCollection 2019.
2
Quantificational evaluation of the resolving power of qualitative biomarkers with different cardinal numbers based on a magnitude-standardized index.基于幅度标准化指数的不同基数定性生物标志物分辨率的定量评估。
J Bioinform Comput Biol. 2020 Dec;18(6):2050036. doi: 10.1142/S0219720020500365. Epub 2020 Oct 15.
3
The combined prognostic significance of alkaline phosphatase and vascular calcification in patients with end-stage kidney disease.碱性磷酸酶和血管钙化对终末期肾病患者的联合预后意义。
Nutr Metab Cardiovasc Dis. 2020 Aug 28;30(9):1476-1483. doi: 10.1016/j.numecd.2020.04.029. Epub 2020 May 12.
4
Comparison of Lymphocyte Count, Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Predicting the Severity and the Clinical Outcomes of Acute Cerebral Infarction Patients.淋巴细胞计数、中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在预测急性脑梗死患者严重程度及临床结局中的比较
Clin Lab. 2019 Jul 1;65(7). doi: 10.7754/Clin.Lab.2019.190102.
5
Evaluation of lipoprotein-associated phospholipase A2, serum amyloid A, and fibrinogen as diagnostic biomarkers for patients with acute cerebral infarction.评价脂蛋白相关磷脂酶 A2、血清淀粉样蛋白 A 和纤维蛋白原作为急性脑梗死患者的诊断生物标志物。
J Clin Lab Anal. 2020 Mar;34(3):e23084. doi: 10.1002/jcla.23084. Epub 2019 Nov 11.
6
Cystatin C as an index of acute cerebral infraction recurrence: one-year follow-up study.胱抑素C作为急性脑梗死复发指标的一年随访研究。
Int J Neurosci. 2019 Jan;129(1):36-41. doi: 10.1080/00207454.2018.1503180.
7
Peripheral Th17/Treg imbalance in patients with atherosclerotic cerebral infarction.动脉粥样硬化性脑梗死患者外周血Th17/Treg失衡
Int J Clin Exp Pathol. 2013 May 15;6(6):1015-27. Print 2013.
8
Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis.急诊科诊断急性心肌缺血生物标志物的准确性:一项荟萃分析。
Ann Emerg Med. 2001 May;37(5):478-94. doi: 10.1067/mem.2001.114905.
9
Predictive value of abdominal aortic calcification index for mid-term cardiovascular events in patients with acute coronary syndrome.腹主动脉钙化指数对急性冠状动脉综合征患者中期心血管事件的预测价值。
Heart Vessels. 2020 May;35(5):620-629. doi: 10.1007/s00380-019-01527-6. Epub 2019 Nov 9.
10
Diagnostic Values of Neutrophil and Neutrophil to Lymphocyte Ratio in Distinguishing between Acute Cerebral Infarction and Vertigo.中性粒细胞及中性粒细胞与淋巴细胞比值在鉴别急性脑梗死与眩晕中的诊断价值
Clin Lab. 2019 Aug 1;65(8). doi: 10.7754/Clin.Lab.2019.190208.

引用本文的文献

1
A new pathway for considering trigger factors based on parallel-serial connection models and displaying the relationships of causal factors in low-probability events.基于并串联连接模型考虑触发因素的新途径,并显示低概率事件中因果因素的关系。
BMC Med Res Methodol. 2023 Apr 15;23(1):93. doi: 10.1186/s12874-023-01919-3.
2
Quantitative evaluations of variations using the population mean as a baseline for bioinformatics interpretation.使用群体平均值作为生物信息学解释的基线进行变异的定量评估。
PeerJ. 2023 Feb 24;11:e14955. doi: 10.7717/peerj.14955. eCollection 2023.

本文引用的文献

1
Novel Biomarkers for the Precisive Diagnosis and Activity Classification of Takayasu Arteritis.用于精准诊断和活动分类的多发性大动脉炎新型生物标志物。
Circ Genom Precis Med. 2019 Jan;12(1):e002080. doi: 10.1161/CIRCGEN.117.002080.
2
Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology.体重指数和空腹血糖对辅助生殖技术后妊娠期糖尿病预测的诊断准确性
Int J Fertil Steril. 2019 Apr;13(1):32-37. doi: 10.22074/ijfs.2019.5505. Epub 2019 Jan 6.
3
Serum cytoskeleton-associated protein 4 as a biomarker for the diagnosis of hepatocellular carcinoma.
血清细胞骨架相关蛋白4作为诊断肝细胞癌的生物标志物。
Onco Targets Ther. 2018 Dec 31;12:359-364. doi: 10.2147/OTT.S189425. eCollection 2019.
4
The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis.晚期癌症患者中免疫检查点抑制剂相关肺炎的相对风险和发病率:一项荟萃分析
Front Pharmacol. 2018 Dec 11;9:1430. doi: 10.3389/fphar.2018.01430. eCollection 2018.
5
Estimation of a Relative Risk Effect Size when Using Continuous Outcomes Data: An Application of Methods in the Prevention of Major Depression and Eating Disorders.使用连续结局数据估计相对风险效应大小:预防重性抑郁障碍和进食障碍中的方法应用。
Med Decis Making. 2018 Oct;38(7):866-880. doi: 10.1177/0272989X18793394. Epub 2018 Aug 29.
6
Genetic risk analysis for an individual according to the theory of programmed onset, illustrated by lung and liver cancers.根据程序性发病理论对个体进行遗传风险分析,以肺癌和肝癌为例。
Gene. 2018 Oct 5;673:107-111. doi: 10.1016/j.gene.2018.06.044. Epub 2018 Jun 15.
7
Genetic and environmental-genetic interaction rules for the myopia based on a family exposed to risk from a myopic environment.基于处于近视环境风险中的一个家庭的近视遗传及环境-遗传相互作用规律
Gene. 2017 Aug 30;626:305-308. doi: 10.1016/j.gene.2017.05.051. Epub 2017 May 25.
8
A Cross-Validation Design Using Age and HLA Alleles for the Assessment of Clinical Schizophrenia Risk.一种使用年龄和人类白细胞抗原(HLA)等位基因进行临床精神分裂症风险评估的交叉验证设计
Clin Lab. 2017 Feb 1;63(2):255-260. doi: 10.7754/Clin.Lab.2016.160725.
9
The allele combinations of three loci based on, liver, stomach cancers, hematencephalon, COPD and normal population: A preliminary study.基于肝癌、胃癌、脑溢血、慢性阻塞性肺疾病及正常人群的三个基因座的等位基因组合:一项初步研究。
Gene. 2017 Mar 20;605:123-130. doi: 10.1016/j.gene.2016.12.031. Epub 2016 Dec 29.
10
Establishment of a method for measuring total complement activity based on a hemolysis system using own red blood cells.建立一种基于使用自身红细胞的溶血系统来测量总补体活性的方法。
J Immunol Methods. 2016 Mar;430:21-7. doi: 10.1016/j.jim.2016.01.010. Epub 2016 Jan 22.